Literature DB >> 29987596

Therapeutic options in advanced heart failure.

Tarek Bekfani1, Florian Westphal1, P Christian Schulze2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29987596     DOI： 10.1007/s00392-018-1318-z

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   5.460


× No keyword cloud information.
  31 in total

Review 1.  Mechanical circulatory support for advanced heart failure: patients and technology in evolution.

Authors:  Garrick C Stewart; Michael M Givertz
Journal:  Circulation       Date:  2012-03-13       Impact factor: 29.690

2.  Sixth INTERMACS annual report: a 10,000-patient database.

Authors:  James K Kirklin; David C Naftel; Francis D Pagani; Robert L Kormos; Lynne W Stevenson; Elizabeth D Blume; Marissa A Miller; J T Baldwin; J Timothy Baldwin; James B Young
Journal:  J Heart Lung Transplant       Date:  2014-04-21       Impact factor: 10.247

3.  2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure.

Authors:  Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2016-12

4.  Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: Results From the ROADMAP Study.

Authors:  Jerry D Estep; Randall C Starling; Douglas A Horstmanshof; Carmelo A Milano; Craig H Selzman; Keyur B Shah; Matthias Loebe; Nader Moazami; James W Long; Josef Stehlik; Vigneshwar Kasirajan; Donald C Haas; John B O'Connell; Andrew J Boyle; David J Farrar; Joseph G Rogers
Journal:  J Am Coll Cardiol       Date:  2015-10-20       Impact factor: 24.094

Review 5.  Clinical pharmacokinetics of drugs in patients with heart failure: an update (part 2, drugs administered orally).

Authors:  Ryuichi Ogawa; Joan M Stachnik; Hirotoshi Echizen
Journal:  Clin Pharmacokinet       Date:  2014-12       Impact factor: 6.447

Review 6.  Patient selection for left ventricular assist devices.

Authors:  Prateeti Khazanie; Joseph G Rogers
Journal:  Congest Heart Fail       Date:  2011-07-21

7.  Advanced (stage D) heart failure: a statement from the Heart Failure Society of America Guidelines Committee.

Authors:  James C Fang; Gregory A Ewald; Larry A Allen; Javed Butler; Cheryl A Westlake Canary; Monica Colvin-Adams; Michael G Dickinson; Phillip Levy; Wendy Gattis Stough; Nancy K Sweitzer; John R Teerlink; David J Whellan; Nancy M Albert; Rajan Krishnamani; Michael W Rich; Mary N Walsh; Mark R Bonnell; Peter E Carson; Michael C Chan; Daniel L Dries; Adrian F Hernandez; Ray E Hershberger; Stuart D Katz; Stephanie Moore; Jo E Rodgers; Joseph G Rogers; Amanda R Vest; Michael M Givertz
Journal:  J Card Fail       Date:  2015-05-04       Impact factor: 5.712

8.  The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure-a meta-regression analysis.

Authors:  Simon Thackray; Joanne Easthaugh; Nick Freemantle; John G F Cleland
Journal:  Eur J Heart Fail       Date:  2002-08       Impact factor: 15.534

Review 9.  Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials.

Authors:  Jin M Cheng; Corstiaan A den Uil; Sanne E Hoeks; Martin van der Ent; Lucia S D Jewbali; Ron T van Domburg; Patrick W Serruys
Journal:  Eur Heart J       Date:  2009-07-18       Impact factor: 29.983

10.  Effect of phosphodiesterase inhibitors on survival of patients with chronic congestive heart failure.

Authors:  M Packer
Journal:  Am J Cardiol       Date:  1989-01-03       Impact factor: 2.778
View more
  7 in total

1.  Severe eosinophilic myocarditis associated with modafinil in a patient with normal peripheral eosinophil count.

Authors:  Marina Bäuml; Josefina Udi; Karin Klingel; Christoph Bode; Klaus Warnatz; Andreas Zirlik; Daniel Duerschmied; Paul Biever
Journal:  Clin Res Cardiol       Date:  2019-02-12       Impact factor: 5.460

2.  Recovery from left ventricular dysfunction was associated with the early introduction of heart failure medical treatment in cancer patients with anthracycline-induced cardiotoxicity.

Authors:  Kisho Ohtani; Takeo Fujino; Tomomi Ide; Kouta Funakoshi; Ichirou Sakamoto; Ken-Ichi Hiasa; Taiki Higo; Kenjiro Kamezaki; Koichi Akashi; Hiroyuki Tsutsui
Journal:  Clin Res Cardiol       Date:  2018-10-26       Impact factor: 5.460

3.  Implementation of an intensified outpatient follow-up protocol improves outcomes in patients with ventricular assist devices.

Authors:  Sonja Hamed; Bastian Schmack; Florian Mueller; Philipp Ehlermann; Davina Hittmann; Arjang Ruhparwar; Hugo A Katus; Philip W Raake; Michael M Kreusser
Journal:  Clin Res Cardiol       Date:  2019-03-16       Impact factor: 5.460

4.  Diuretic treatment in high-risk acute decompensation of advanced chronic heart failure-bolus intermittent vs. continuous infusion of furosemide: a randomized controlled trial.

Authors:  Simone Frea; Stefano Pidello; Alessandra Volpe; Federico Giovanni Canavosio; Alessandro Galluzzo; Virginia Bovolo; Antonio Camarda; Pier Giorgio Golzio; Fabrizio D'Ascenzo; Serena Bergerone; Mauro Rinaldi; Fiorenzo Gaita
Journal:  Clin Res Cardiol       Date:  2019-06-29       Impact factor: 5.460

Review 5.  [Update on diagnostics and treatment of heart failure].

Authors:  Jan Wintrich; Ann-Kathrin Berger; Yvonne Bewarder; Insa Emrich; Jonathan Slawik; Michael Böhm
Journal:  Herz       Date:  2021-08-31       Impact factor: 1.740

6.  The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure.

Authors:  Ahmad A Cluntun; Rachit Badolia; Sandra Lettlova; K Mark Parnell; Thirupura S Shankar; Nikolaos A Diakos; Kristofor A Olson; Iosif Taleb; Sean M Tatum; Jordan A Berg; Corey N Cunningham; Tyler Van Ry; Alex J Bott; Aspasia Thodou Krokidi; Sarah Fogarty; Sophia Skedros; Wojciech I Swiatek; Xuejing Yu; Bai Luo; Shannon Merx; Sutip Navankasattusas; James E Cox; Gregory S Ducker; William L Holland; Stephen H McKellar; Jared Rutter; Stavros G Drakos
Journal:  Cell Metab       Date:  2020-12-16       Impact factor: 27.287

Review 7.  Nanomaterials for Cardiac Tissue Engineering.

Authors:  Devang R Amin; Eric Sink; Suguna P Narayan; Mostafa Abdel-Hafiz; Luisa Mestroni; Brisa Peña
Journal:  Molecules       Date:  2020-11-07       Impact factor: 4.411
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.